An Inquiry on the Social and Education Status of Women from Northern Cameroon Suffering Cervical Cancer and the State of Knowledge of their Disease
- Authors
-
-
Armel Herve Nwabo Kamdje
Department of Biomedical Sciences, Faculty of Sciences, University of Ngaoundere, Ngaoundere, Cameroun -
Georges Kalgong
Department of Biomedical Sciences, Faculty of Sciences, University of Ngaoundere, Ngaoundere, Cameroun -
Richard Simo Tagne
Department of Biomedical Sciences, Faculty of Sciences, University of Ngaoundere, Ngaoundere, Cameroun -
Jeremie Mbo Amvene
Department of Biomedical Sciences, Faculty of Sciences, University of Ngaoundere, Ngaoundere, Cameroun -
Charlette Nangue
Anato-Cytopathology Laboratory, University Hospital Center of Yaoundé, Yaounde, Cameroun
-
- Keywords:
- Sensitivity, specificity, diagnosis,VIA-VILI, cervical cancer.
- Abstract
-
Background: Cervical cancer is a major cause of women death worldwide. The reduction of the mortality and morbidity of this pathology depends on the early detection based on powerful suitable screening methods, that will lead to optimal treatment strategies. However in some rural region of developing countries, it is very difficult to get access to standard screening methods, alternative screening methods, cheaper and easy to handle are then useful.
Objective: The aim of this work was to test the sensitivity and specificity of VIA (Visual inspection with acetic acid) and VILI (Visual inspection with lugol iodine) as screening test of cervical cancer compared to the Pap Smear, evaluating the feasibility in health formation in the North Cameroon region, of implementing epidemiological surveillance of cervical cancer based on early diagnosis using the VIA-VILI association
Method: 309 women age 20 to 62 years were recruited in this study, 307 were included in the statistical analyzes. Each woman was screened for cervical cancer by a conventional Smear and visual inspection with acetic acid 5% and the lugol solution.
Results: We found in our study a prevalence of precancerous lesions of cervix at 12.70%. The risks factors of cervical cancer identified are age, matrimonial status, age of first sexual intercourse and parity. The association of VIA and VILI showed a sensitivity, specificity, positive and negative predictive value respectively about 93.58%; 97.01%; 82.01%, 99.04%.
Conclusion: Compared to PAP Smear, VIA or VILI could be used as an alternative screening methods for cervical cancer in developing countries. However, histology test was recommended to use a « Gold Standard » to evaluate the test accuracy of VIA/VILI because it can be used to diagnose cancer, while PAP smear cannot.
- Downloads
- Published
- 2021-08-20
- Issue
- Vol. 6 No. 4 (2017)
- Section
- Articles
How to Cite
Similar Articles
- Paola Castro-Garcia, Carmen Gil-Gas, Paloma Honrubia-Gómez, Carmen Belen Alvarez-Simón, Jesús-José Ferré-Fernández, Francisco Sánchez-Sánchez, Jose Luis Sánchez-Sánchez, Jose Mª Garcia-Bueno, Sebastiá Sabater, Guadalupe Aparicio, Luis Miguel Antón-Aparicio, Carmen Ramírez-Castillejo, C-Terminal-PEDF Reduces IC50 Doses and Chemoresistant Population of CD133 and BCRP1-Positve Cancer Stem Like Cells , Journal of Analytical Oncology: Vol. 2 No. 4 (2013)
- Rehanna Mansor, Amit Bahl, Jeff Holly , Claire M. Perks , The Role of the IGF Axis in Epithelial-to-Mesenchymal Transition during the Progression of Prostate Cancer , Journal of Analytical Oncology: Vol. 4 No. 4 (2015)
- Anshika N. Singh, Anand P. Khandwekar , Neeti Sharma, Cancer Stem-Cell Related miRNAs: Novel Potential Targets for Metastatic Prostate Cancer , Journal of Analytical Oncology: Vol. 4 No. 4 (2015)
- Kenneth K. Wu, Tryptophan Metabolism and Cancer Progression , Journal of Analytical Oncology: Vol. 10 (2021)
- Juan Pablo Nicola, Ana María Masini-Repiso, Emerging Therapeutics for Radioiodide-Refractory Thyroid Cancer , Journal of Analytical Oncology: Vol. 5 No. 2 (2016)
- Tommaso Cai, Gabriella Nesi, Sandra Mazzoli, Francesca Meacci, Galliano Tinacci, Cesare Selli , Riccardo Bartoletti , Inflammation and Urothelial Bladder Cancer: What we Need to Known? (Review) , Journal of Analytical Oncology: Vol. 4 No. 2 (2015)
- Hiroko Ina, Kenji Ina, Megumi Kabeya, Satoshi Kayukawa, Takashi Yoshida, Masahiko Yoneda, Lentinan, a Shiitake Mushroom ß-Glucan, Downregulates the Enhanced PD-L1 Expression Induced by Platinum Compounds in Gastric Cancer Cells - , Journal of Analytical Oncology: Vol. 9 (2020)
- Abbas Rezaianzadeh, Soheil Hassanipour Azgomi, Ali Mohammad Mokhtari, Ahmad Maghsoudi, Milad Nazarzadeh, Seyedeh Leila Dehghan, Salar Rahimi Kazerooni, The Incidence of Breast Cancer in Iran: A Systematic Review and Meta-Analysis , Journal of Analytical Oncology: Vol. 5 No. 4 (2016)
- Lies Pottel, Michelle Lycke, Tom Boterberg, Lore Ketelaars, Hans Pottel, Laurence Goethals, Nele Van den Noortgate, Fréderic Duprez, Wilfried De Neve, Sylvie Rottey, Kurt Geldhof, Koen Van Eygen, Khalil Kargar-Samani, Véronique Ghekiere, Anne Verhaeghe, Philip R. Debruyne, Experience with Lexicomp® Online Drug Database for Medication Review and Drug-Drug Interaction Analysis within a Comprehensive Geriatric Assessment in Elderly Cancer Patients , Journal of Analytical Oncology: Vol. 1 No. 1 (2012)
- Hassan Akbari, Farzad Taghizadeh Hesary, Laya Rahnar Nikoukar, Distribution of Breast Cancer Biomarkers by Age in Iran , Journal of Analytical Oncology: Vol. 6 No. 1 (2017)
You may also start an advanced similarity search for this article.